MaxCyte Balance Sheet Health
Financial Health criteria checks 6/6
MaxCyte has a total shareholder equity of $213.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $248.6M and $35.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$153.83m |
| Equity | US$213.30m |
| Total liabilities | US$35.31m |
| Total assets | US$248.61m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MYE0's short term assets ($172.9M) exceed its short term liabilities ($17.6M).
Long Term Liabilities: MYE0's short term assets ($172.9M) exceed its long term liabilities ($17.7M).
Debt to Equity History and Analysis
Debt Level: MYE0 is debt free.
Reducing Debt: MYE0 has no debt compared to 5 years ago when its debt to equity ratio was 36%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MYE0 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MYE0 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 21.3% each year